Centrient Pharmaceuticals (until December 2018 known as DSM Sinochem Pharmaceuticals) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. Centrient develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition. Headquartered in Rotterdam, Netherlands, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital, a leading global investment firm.
View Top Employees from DSM Sinochem PharmaceuticalsWebsite | http://www.centrient.com |
Revenue | $911 million |
Employees | 468 (278 on RocketReach) |
Founded | 1869 |
Phone | +31 15 279 3485 |
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Sustainable Antibiotics, Retail, Enzymatically produced beta-lactam antibiotics, Enzymatically produced statins, Enzymatically produced generic APIs, Drug Products with PureActives API |
Web Rank | 6 Million |
Keywords | Pharmaceutical Solutions, Active Pharmaceutical Ingredients |
Competitors | Aarti Drugs Limited, Aurobindo Pharma, Hovione, Laurus Labs Limited, Siegfried Holding AG |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular DSM Sinochem Pharmaceuticals employee's phone or email?
The DSM Sinochem Pharmaceuticals annual revenue was $911 million in 2024.
Rajesh Salwan is the Vice President Operations and Technology of DSM Sinochem Pharmaceuticals.
278 people are employed at DSM Sinochem Pharmaceuticals.
The NAICS codes for DSM Sinochem Pharmaceuticals are [3254, 32541, 325, 32].
The SIC codes for DSM Sinochem Pharmaceuticals are [28, 283].